Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection
Following neurotrauma, secondary degeneration of neurons and glia adjacent to the injury leads to further functional loss. A combination of ion channel inhibitors (lomerizine + oxATP + YM872) has been shown to be effective at limiting structural and functional loss due to secondary degeneration. Here we assess efficacy of the combination where oxATP is replaced with Brilliant Blue G (BBG), a more clinically applicable P2X7 receptor inhibitor. Partial optic nerve transection was used to model secondary degeneration in adult female rats. Animals were treated with combinations of lomerizine + YM872 + oxATP or lomerizine + YM872 + BBG, delivered via osmotic mini-pump directly to the injury site. Outcomes assessed were Iba1 + and ED1 + microglia and macrophages, oligodendroglial cell numbers, node/paranode structure and visual function using the optokinetic nystagmus test. The lomerizine + BBG + YM872 combination was at least as effective at the tested concentrations as the lomerizine + oxATP + YM872 combination at preserving node/paranode structure and visual function when delivered locally. However, neither ion channel inhibitor combination significantly improved microglial/macrophage nor oligodendroglial numbers compared to vehicle-treated controls. In conclusion, a locally delivered combination of ion channel inhibitors incorporating lomerizine + BBG + YM872 is at least as effective at limiting secondary degeneration following partial injury to the optic nerve as the combination incorporating oxATP.
KeywordsSecondary degeneration Neurotrauma Ion channel inhibitor Myelin Visual function
MF is supported by an NHMRC Career Development Fellowship (APP1087114).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Banik NL, McAlhaney WW, Hogan EL (1985) Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem 45:581–588. https://doi.org/10.1111/j.1471-4159.1985.tb04026.x CrossRefGoogle Scholar
- Borzelleca JF, Depukat K, Hallagan JB (1990) Lifetime toxicity/carcinogenicity studies of FD & C Blue No. 1 (brilliant blue FCF) in rats and mice. Food Chem Toxicol 28:221–234Google Scholar
- Diaz-Hernandez JI, Gomez-Villafuertes R, León-Otegui M et al (2012) In vivo P2 × 7 inhibition reduces amyloid plaques in Alzheimer’s disease through GSK3β and secretases. Neurobiol Aging 33:1816–1828. https://doi.org/10.1016/j.neurobiolaging.2011.09.040 CrossRefGoogle Scholar
- Farooqui AA, Ong W-Y, Horrocks LA (2008) Neurochemical aspects of excitotoxicity. Springer, New YorkGoogle Scholar
- Fitzgerald M, Bartlett CA, Payne SC, Hart NS, Rodger J, Harvey AR, Dunlop SA (2010b) Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve. J Neurotrauma 27:2107–2119. https://doi.org/10.1089/neu.2010.1426 CrossRefGoogle Scholar
- Levkovitch-Verbin H, Quigley HA, Martin KRG, Zack DJ, Pease ME, Valenta DF (2003) A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Investig Opthalmol Vis Sci 44:3388–3388. https://doi.org/10.1167/iovs.02-0646 CrossRefGoogle Scholar
- Mirron V, Kuhlmann T, Antel J (2011) Cells of the oligodendroglial lineage, myelination and remyelination. Biochem Biophys Acta 1812:184–193Google Scholar
- Shields DC, Deiber GE, Banik NL (1997) Calpain: a mediator of myelin breakdown in demyelinating diseases. Ann N Y Acad Sci 825:128–130. https://doi.org/10.1111/j.1749-6632.1997.tb48422.x CrossRefGoogle Scholar
- Tymianski M, Charles T (1996) Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38:1176–1195Google Scholar